Noninvasive Biomarkers in Assessment of Liver Fibrosis in Patients with HBeAg Negative Chronic Hepatitis B

BACKGROUND: Liver biopsy for evaluation of liver fibrosis has several adverse effects, for which reason noninvasive tests have been developed. AIM: To evaluate the usefulness of noninvasive biomarkers, qHBsAg and HBV DNA levels in predicting liver fibrosis in patients with hepatitis Be antigen (HBeA...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Open Access Maced J Med Sci
Egile Nagusiak: Dimzova, Marija, Kondova-Topuzovska, Irena, Bosilkovski, Mile, Ivanovski, Ljubomir, Milenkovic, Zvonko, Semenakova-Cvetkovska, Vesna, Orovcanec, Nikola
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Republic of Macedonia 2018
Gaiak:
Clinical Science
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6026435/
https://ncbi.nlm.nih.gov/pubmed/29983800
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3889/oamjms.2018.122
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak